#USA #Beijing #Laser Technology #Wingderm #Renuva 1550nm

Wingderm® Achieves MDR Certification

Wingderm® has exciting news for the beauty and aesthetic medical community. The company has announced that its non-ablative fractional laser system, the Renuva 1550nm, has received certification under the Medical Device Regulation (MDR) in the European Union. This marks a pivotal regulatory achievement for the device, allowing it to be marketed effectively within one of the world's most stringent regulatory environments.

About Renuva

The Renuva 1550nm system is designed to treat a variety of skin conditions, including acne scars and stretch marks, across skin types Fitzpatrick I to VI. Prior to obtaining the MDR certification, Renuva was already compliant with the Medical Device Directive (MDD) in the EU. Transitioning to MDR compliance reflects Wingderm's commitment to meeting the latest standards in medical device regulations.

The Renuva system employs a technology known as fractional photothermolysis, which delivers a controlled energy output to micro-zones of skin while preserving the surrounding tissue. This technique aims to improve skin appearance in a manner that is both effective and minimally disruptive to the patient's daily life. Clients can expect to resume their regular activities shortly after treatment sessions, reinforcing Renuva's reputation as a patient-friendly option.

Feedback from Professionals

Professionals in the cosmetic field have provided encouraging feedback about the Renuva procedures. Dr. Martyn King, Vice President of the Joint Council of Cosmetic Practitioners and a member of the British College of Aesthetic Medicine, noted, "Renuva may be combined with other aesthetic services or used independently as part of a treatment program. Patients generally return to their normal activities shortly after each session, with many describing the experience as well-tolerated."

Interestingly, the treatment has gained popularity among male clients, who often report finding the experience comfortable and the disruption to their lives minimal. The MDR certification not only solidifies Renuva's position within the market but also provides clinics with a regulated technological option for aesthetic programs.

Wider availability of Renuva will empower beauty professionals to offer innovative, safe, and customizable skin enhancement treatments, thus enhancing the landscape of aesthetic medicine.

About Wingderm®

Founded in 2016, Wingderm® has adhered to its mission of providing reliable and high-quality aesthetic medical devices. The company has successfully exported its products to over 80 countries, with more than 25,000 units installed globally. Wingderm® is recognized for its commitment to safety and effectiveness, achieving strong endorsements from beauty experts and patients alike.

Those seeking more information about the Renuva system and other products can visit their official website. Wingderm continues to lead the way in aesthetic technology, making aesthetic procedures accessible and effective for all.